Phase II
Regulating Blood Pressure During Recovery from Intracerebral Hemorrhage (REDUCE)
- Study HIC#:2000029811
- Last Updated:12/22/2022
This study is looking to compare the effect of spironolactone-containing antihypertensive medications versus standard antihypertensive medications on home blood pressure in intracerebral hemorrhage (ICH) survivors.
- Age18 years and older
- GenderBoth
- Start Date04/07/2021
- End Date01/31/2025
Eligibility Criteria
Inclusion Criteria:
Symptomatic ICH within the past 6 months
